{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:02:30Z","timestamp":1774965750708,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Open Targets"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The Open Targets Platform (https:\/\/www.targetvalidation.org\/) provides users with a queryable knowledgebase and user interface to aid systematic target identification and prioritisation for drug discovery based upon underlying evidence. It is publicly available and the underlying code is open source. Since our last update two years ago, we have had 10 releases to maintain and continuously improve evidence for target\u2013disease relationships from 20 different data sources. In addition, we have integrated new evidence from key datasets, including prioritised targets identified from genome-wide CRISPR knockout screens in 300 cancer models (Project Score), and GWAS\/UK BioBank statistical genetic analysis evidence from the Open Targets Genetics Portal. We have evolved our evidence scoring framework to improve target identification. To aid the prioritisation of targets and inform on the potential impact of modulating a given target, we have added evaluation of post-marketing adverse drug reactions and new curated information on target tractability and safety. We have also developed the user interface and backend technologies to improve performance and usability. In this article, we describe the latest enhancements to the Platform, to address the fundamental challenge that developing effective and safe drugs is difficult and expensive.<\/jats:p>","DOI":"10.1093\/nar\/gkaa1027","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T20:18:15Z","timestamp":1605125895000},"page":"D1302-D1310","source":"Crossref","is-referenced-by-count":443,"title":["Open Targets Platform: supporting systematic drug\u2013target identification and prioritisation"],"prefix":"10.1093","volume":"49","author":[{"given":"David","family":"Ochoa","sequence":"first","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Andrew","family":"Hercules","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Miguel","family":"Carmona","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Daniel","family":"Suveges","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Asier","family":"Gonzalez-Uriarte","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Cinzia","family":"Malangone","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Alfredo","family":"Miranda","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Luca","family":"Fumis","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Denise","family":"Carvalho-Silva","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Michaela","family":"Spitzer","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Jarrod","family":"Baker","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Javier","family":"Ferrer","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Arwa","family":"Raies","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Olesya","family":"Razuvayevskaya","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Adam","family":"Faulconbridge","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Eirini","family":"Petsalaki","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Prudence","family":"Mutowo","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK"}]},{"given":"Sandra","family":"Machlitt-Northen","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK"}]},{"given":"Gareth","family":"Peat","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Elaine","family":"McAuley","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Chuang\u00a0Kee","family":"Ong","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Edward","family":"Mountjoy","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK"}]},{"given":"Maya","family":"Ghoussaini","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK"}]},{"given":"Andrea","family":"Pierleoni","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Eliseo","family":"Papa","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Systems Biology, Biogen, Cambridge, MA\u00a002142, USA"}]},{"given":"Miguel","family":"Pignatelli","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]},{"given":"Gautier","family":"Koscielny","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK"}]},{"given":"Mohd","family":"Karim","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK"}]},{"given":"Jeremy","family":"Schwartzentruber","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK"}]},{"given":"David G","family":"Hulcoop","sequence":"additional","affiliation":[{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK"}]},{"given":"Ian","family":"Dunham","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK"}]},{"given":"Ellen\u00a0M","family":"McDonagh","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"},{"name":"Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK"}]}],"member":"286","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"2021010313122813700_B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"Dimasi","year":"2016","journal-title":"J. Health Econ."},{"key":"2021010313122813700_B2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"2021010313122813700_B3","doi-asserted-by":"crossref","first-page":"D1056","DOI":"10.1093\/nar\/gky1133","article-title":"Open Targets Platform: new developments and updates two years on","volume":"47","author":"Carvalho-Silva","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B4","doi-asserted-by":"crossref","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open Targets: a platform for therapeutic target identification and validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B5","doi-asserted-by":"crossref","first-page":"e1008489","DOI":"10.1371\/journal.pgen.1008489","article-title":"Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval","volume":"15","author":"King","year":"2019","journal-title":"PLoS Genet."},{"key":"2021010313122813700_B6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"2021010313122813700_B7","article-title":"Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics","author":"Ghoussaini","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B8","first-page":"D682","article-title":"Ensembl 2020","volume":"48","author":"Yates","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B9","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"2021010313122813700_B11","first-page":"19","article-title":"The structural genomics consortium: a knowledge platform for drug discovery: a summary","volume":"4","author":"Jones","year":"2014","journal-title":"Rand Health Q."},{"key":"2021010313122813700_B12","doi-asserted-by":"crossref","first-page":"e34311","DOI":"10.7554\/eLife.34311","article-title":"Donated chemical probes for open science","volume":"7","author":"M\u00fcller","year":"2018","journal-title":"eLife"},{"key":"2021010313122813700_B13","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0018578718795271","article-title":"The newly available FAERS public dashboard: implications for health care professionals","volume":"54","author":"Kumar","year":"2018","journal-title":"Hosp. Pharm."},{"key":"2021010313122813700_B15","doi-asserted-by":"crossref","first-page":"e25818","DOI":"10.7554\/eLife.25818","article-title":"Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets","volume":"6","author":"Maciejewski","year":"2017","journal-title":"eLife"},{"key":"2021010313122813700_B16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10543406.2013.736810","article-title":"Likelihood ratio test-based method for signal detection in drug classes using FDA\u2019s AERS database","volume":"23","author":"Huang","year":"2013","journal-title":"J. Biopharm. Stat."},{"key":"2021010313122813700_B17","first-page":"1112","article-title":"Modeling sample variables with an experimental factor ontology","author":"Malone","year":"2010"},{"key":"2021010313122813700_B18","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B19","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B20","first-page":"D77","article-title":"Expression Atlas update: from tissues to single cells","volume":"48","author":"Papatheodorou","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"2021010313122813700_B22","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gku1061","article-title":"Europe PMC: a full-text literature database for the life sciences and platform for innovation","volume":"43","author":"consortium","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"2021010313122813700_B24","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat. Genet."},{"key":"2021010313122813700_B26","doi-asserted-by":"crossref","first-page":"D704","DOI":"10.1093\/nar\/gkz997","article-title":"The monarch initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species","volume":"48","author":"Shefchek","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/C7MD00633K","article-title":"Approaches to target tractability assessment \u2013 a practical perspective","volume":"9","author":"Brown","year":"2018","journal-title":"MedChemComm"},{"key":"2021010313122813700_B28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd3845","article-title":"Reducing safety-related drug attrition: the use of in vitro pharmacological profiling","volume":"11","author":"Bowes","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313122813700_B29","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2017.02.020","article-title":"Potential functional and pathological side effects related to off-target pharmacological activity","author":"Lynch","year":"2017"},{"key":"2021010313122813700_B30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd3252","article-title":"Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes","volume":"10","author":"Force","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021010313122813700_B31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/toxsci\/kfx082","article-title":"Deconvoluting kinase inhibitor induced cardiotoxicity","volume":"158","author":"Lamore","year":"2017","journal-title":"Toxicol. Sci."},{"key":"2021010313122813700_B32","first-page":"21136","article-title":"The eTOX data-sharing project to advance in silico drug-induced toxicity prediction","author":"Cases","year":"2014"},{"key":"2021010313122813700_B33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"J. Toxicol. Environ. Health B"},{"key":"2021010313122813700_B34","doi-asserted-by":"crossref","first-page":"e1006419","DOI":"10.1371\/journal.pcbi.1006419","article-title":"Ten simple rules for delivering live distance training in bioinformatics across the globe using webinars","volume":"14","author":"Carvalho-Silva","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"2021010313122813700_B35","doi-asserted-by":"crossref","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","article-title":"Pharos: collating protein information to shed light on the druggable genome","volume":"45","author":"Nguyen","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B36","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B37","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gky1129","article-title":"canSAR: update to the cancer translational research and drug discovery knowledgebase","volume":"47","author":"Coker","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2021010313122813700_B38","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/bib\/bby071","article-title":"Computational resources associating diseases with genotypes, phenotypes and exposures","volume":"20","author":"Zhang","year":"2019","journal-title":"Brief. Bioinform."},{"key":"2021010313122813700_B39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","article-title":"A genetics-led approach defines the drug target landscape of 30 immune-related traits","volume":"51","author":"Fang","year":"2019","journal-title":"Nat. Genet."},{"key":"2021010313122813700_B40","doi-asserted-by":"crossref","first-page":"e1007276","DOI":"10.1371\/journal.pcbi.1007276","article-title":"Benchmarking network propagation methods for disease gene identification","volume":"15","author":"Picart-Armada","year":"2019","journal-title":"PLoS Comput. Biol."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1302\/35363725\/gkaa1027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/D1\/D1302\/35363725\/gkaa1027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T18:15:52Z","timestamp":1609697752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/49\/D1\/D1302\/5983621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":40,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2020,11,16]]},"published-print":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaa1027","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,8]]},"published":{"date-parts":[[2020,11,16]]}}}